in a randomized , double-blind placebo-controlled clinical trial , we evaluated the prophylactic effectiveness of rimantadine in children ( ages 1 to 18 years ) against infection with influenza a ( h3n2 ) and associated illness and the prevention of transmission of infection to adult members of the child 's family .
C0035629
rimantadine
C0021400
influenza